Results 251 to 260 of about 74,143 (357)

Non-Invasive Biomarkers for Eosinophilic Esophagitis: Latest Developments and Future Directions. [PDF]

J Clin Med
Marulo S, Macrì A, Mirabelli P, Aurino L, Turco R, Franca RA, Quitadamo P.   +6 more
europepmc   +1 more source

Drooling as a Red Flag: Insights From a Case Series in Severe Dermatomyositis With Literature Review

Clinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT Dermatomyositis (DM) is a rare idiopathic inflammatory disease characterized by progressive proximal muscle weakness and distinctive dermatologic manifestations. Although dysphagia is a recognized complication of oropharyngeal muscle involvement, drooling (sialorrhea) is infrequently described and may be a marker of severe disease.
Alireza Mirzamohamadi, Shokufe Sadeghi, Yalda Nilipour, Somayeh Motamed, Vahid Ardestani Rostami, Ahmadreza Jamshidi, Masoomeh Akhlaghi, Hoda Kavoosi, Majid Alikhani, Seyedeh Tahereh Faezi   +9 more
wiley   +1 more source

Optimizing radiation dose and fractionation for the definitive treatment of locally advanced non-small cell lung cancer [PDF]

, 2018
Bradley, Jeffrey D, Roach, Michael C, Robinson, Cliff G   +2 more
core   +1 more source

Severe Bleeding due to Cytomegalovirus Esophagitis in a Patient with Diabetes after Interbody Fusion Surgery

, 2019
Shumpei Yamamoto, Masaya Iwamuro, Muneaki Miyake, Naoyuki Nishimura, Motowo Mizuno, Hiroyuki Okada   +5 more
openalex   +2 more sources

Management of Refractory Eosinophilic Esophagitis [PDF]

, 2014
Vincent A. Mukkada, Glenn T. Furuta
openalex   +1 more source

Response to Proton-Pump Inhibitors Therapy in Pediatric Patients With Eosinophilic Esophagitis in Bogotá, Colombia. [PDF]

Can J Gastroenterol Hepatol
Rodríguez López AE, Vera Chamorro JF, Carias Domínguez AM, Pinilla Roncancio MV, López Panqueva RDP, Montaño Rozo GA.   +5 more
europepmc   +1 more source

Safety and Efficacy of Very Low‐Dose Multi‐Nut Oral Immunotherapy in Children

Clinical and Translational Allergy, Volume 15, Issue 12, December 2025.
ABSTRACT Background Oral immunotherapy (OIT) is a management strategy for food allergies, typically one at a time, with maintenance doses ≥ 300 mg protein. However, 30% of allergic children have multiple trigger foods, and large maintenance doses are associated with side effects. If efficacious, Very Low‐Dose OIT (VLOIT) may enhance safety in multi‐OIT.
Julia E. M. Upton, Carmen H. Li, Alireza Berenjy, Alana Galper, Xiaojun Yin, Alper Celik, Lucy Duan, Samantha Wong, Christina M. Ditlof, Kristen E. San Diego, Jennifer A. Hoang, Moshe Ben‐shoshan, Akash Kothari, Lisa Hung, Mikhail Monteiro, Wut Hmone Phue, Theo J. Moraes, Thomas Eiwegger   +17 more
wiley   +1 more source

Tegoprazan Versus Proton Pump Inhibitors for Erosive Esophagitis: A Meta-Analysis of Noninferiority Randomized Controlled Trials. [PDF]

JGH Open
Bhatti MI, Safiullah M, Ijaz A, Mehmood Q, Shahid IF, Shahriar Z.   +5 more
europepmc   +1 more source

Central blood volume in cirrhosis [PDF]

, 1993
Bendtsen, Flemming, Gerbes, Alexander L., Henriksen, Jens H.   +2 more
core   +1 more source

Atopic Multimorbidity in Adults With a Focus on Sensitization Patterns and T Cell Activation

Clinical and Translational Allergy, Volume 15, Issue 12, December 2025.
Our study looked at atopic dermatitis and atopic comorbidities (rhinitis, asthma) with regards to type 1 allergic sensitizations, serum IgE values and systemic T cell activation. Our results show that IgE values increase with atopic disease burden while T cell activation is rather dependent on disease activity than atopic multimorbidity.
Ariane Bialas, Marie Rabe, Niklas Artz, Andreas Boldt, Jan C. Simon, Regina Treudler, Benjamin Klein   +6 more
wiley   +1 more source